KODIAK SCIENCES INC. Investments and Cash
KODIAK SCIENCES INC. (KOD) had Investments and Cash of $125.90 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets
us-gaap:InvestmentsAndCash · last filed 2026-08-13
- 2026-06-30: Investments and Cash $125.90M.
- 2026-03-31: Investments and Cash $169.50M.
- 2025-12-31: Investments and Cash $209.90M.
- 2025-09-30: Investments and Cash $72.00M.
| Period end | Investments and Cash |
|---|---|
| 2026-06-30 | $125.90M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $169.50M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $209.90M 10-K · filed 2026-03-31 |
| 2025-09-30 | $72.00M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $104.20M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $138.90M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $168.10M 10-K · filed 2025-03-27 |
| 2024-09-30 | $197.90M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $219.20M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $245.90M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $285.50M 10-K · filed 2024-03-28 |
| 2023-09-30 | $345.70M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $378.70M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $421.20M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $478.90M 10-K · filed 2023-03-28 |
| 2022-09-30 | $537.40M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $597.90M 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |